Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Program
On WRAL at 11: Raleigh bar permanently closed after more than 20 years of service. The investigation that prompted the owner to shut down
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biogen Idec
(NQ:
BIIB
)
203.30
-1.56 (-0.76%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Biogen Idec
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
39
40
Next >
The Unexpected Way The Texas Abortion Ruling Could Destroy Biotech
April 14, 2023
One executive called this the most "damaging" decision in five decades.
Via
Investor's Business Daily
New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications
April 12, 2023
New York and California are stockpiling an alternative abortion medication in case a Texas judge's order suspending the FDA approval of the primary drug, mifepristone, goes into effect later this...
Via
Benzinga
Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead
April 11, 2023
In a new court filing, the Democratic attorneys general for 23 U.S. states have reportedly warned that a federal judge's decision to suspend the FDA's approval of mifepristone "presents devastating...
Via
Benzinga
12 Analysts Have This to Say About Biogen
April 11, 2023
Via
Benzinga
A Look Into Biogen's Debt
April 03, 2023
Via
Benzinga
Price Over Earnings Overview: Biogen
March 31, 2023
Via
Benzinga
Biogen Unusual Options Activity
March 23, 2023
Via
Benzinga
11 Analysts Have This to Say About Biogen
March 23, 2023
Via
Benzinga
Despite Failed Phase 3 Study, FDA Staff Says Biogen's ALS Drug May Have Clinical Benefit
March 21, 2023
Via
Benzinga
3 Biotech Stocks to Watch for Potential Breakthroughs
April 11, 2023
These biotech stocks have significant upside and realistic breakthrough chances in the current and distant future.
Via
InvestorPlace
Twitter Inc Is Officially Defunct, Alibaba Plans to Integrate ChatGPT Like Chatbot Across Products, Moderna's Flu Shot Study Misses 'Early Success' Criteria: Today's Top Stories
April 11, 2023
Benzinga Twitter Inc Is Officially Defunct As Elon Musk Pursues' Superapp' Goal
Via
Benzinga
Drugmakers Stand Up for Reproductive Rights: Pfizer and Biogen Among 300 Condemning Abortion Pill Approval Suspension
April 11, 2023
Via
Benzinga
Top-Notch Biotech TG Therapeutics Logs 'Solid Jump' In Sales; Shares Rocket
April 10, 2023
Shares are closing in on a buy point out of a consolidation.
Via
Investor's Business Daily
Should You Buy Biogen Before a Big July Decision?
March 19, 2023
Biogen stock has dropped about 40% from its record high.
Via
The Motley Fool
Price Over Earnings Overview: Biogen
March 17, 2023
Via
Benzinga
(BIIB) - Analyzing Biogen's Short Interest
March 17, 2023
Via
Benzinga
The 3 Best Millionaire-Maker Stocks to Buy for April 2023
April 07, 2023
These millionaire-maker stocks certainly have the growth profiles to help investors reach their goals of becoming a millionaire.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
April 07, 2023
Via
Benzinga
Tesla Manufactured 4,000 Model Ys In One Week, UBS Prepping For Massive Layoffs, McDonald's Temporary Shuttering Of US Offices: Today's Top Stories
April 03, 2023
Bloomberg UBS Prepping For Massive Layoffs Amid Credit Suisse Takeover
Via
Benzinga
National Institute on Aging Aims Building $300M Alzheimer's Research Database
April 03, 2023
The U.S. National Institute on Aging (NIA), part of the government's National Institutes of Health (NIH), aims to build an Alzheimer's research database. Alzheimer's Association Chief Science Officer...
Via
Benzinga
Eisai-Biogen Highlights Additional Data From Recently Approved Alzheimer's Drug
March 31, 2023
Via
Benzinga
7 Blue-Chip Stocks Sitting in the Sweet Spot
March 23, 2023
Although blue-chip stocks carry a reputation for being bulky and not exciting, these large enterprises can really move.
Via
InvestorPlace
Elliott Wave Technical Analysis: Biogen Inc. - Thursday, March 23
March 23, 2023
Looking for longs after a clear resumption of the uptrend.
Via
Talk Markets
Ionis Rockets As Biogen-Partnered ALS Drug Wins Key Endorsement
March 23, 2023
The companies are focusing on a small population of ALS patients with a genetic mutation.
Via
Investor's Business Daily
FDA Adcomm Says Benefit-Risk Profile Favor Biogen's Tofersen For Inherited Neuro Disorder
March 23, 2023
Via
Benzinga
iMetabolic BioPharma's Alzheimer's Disease Therapeutic Innovation Is A Breakthrough Three-Pronged Approach
March 22, 2023
Interested in investing in iMetabolic BioPharma? Click here to get started!
Via
Benzinga
7 Healthcare Stocks to Buy for Long-Term Growth and Stability
March 21, 2023
These healthcare stocks to buy offer spectacular upside potential ahead in your defensive portfolio as we get deeper into 2023.
Via
InvestorPlace
Two Big Pharma Companies Bow Out Of Neurology Drug Partnerships With Sangamo
March 20, 2023
Two big-name partners have walked away from partnerships with Sangamo Therapeutics Inc (NASDAQ: SGMO) over a few days.
Via
Benzinga
Biogen Triumphs In Legal Battle Regarding Tecfidera, Delaying EU Generic Erosion For Another Year
March 16, 2023
Via
Benzinga
Alzheimer's Association Launches Grassroots Level Lobbying For Medicare Coverage Of Alzheimer's Treatments
March 16, 2023
Via
Benzinga
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
39
40
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.